Hereditary Renal Papillary Cancer
1 clinical trials · Condition
◉ Watch Hereditary Renal Papillary Cancer
| Record | Firm | Date |
|---|---|---|
| Study to Determine the Safety and Pharmacokinetics of DO-2 in Patients With Advanced or Refractory Solid Tumours (NCT05752552) | DeuterOncology | 2022-12-20 |
Track Hereditary Renal Papillary Cancer automatically
Every clearance here is in the API, with alerts when new ones post.